ACER Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (20 Nov 2023 @ 15:59):

Acer Therapeutics Inc., a pharmaceutical company, focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases...

Stats
Today's Volume	574 675
Average Volume	2.39M
Market Cap	16.15M
EPS	$-0.600 ( 2024-03-25 )
Next earnings date	( $0 ) 2024-05-13
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.342
ATR14	$0.0570 (8.64%)

Insider Trading

Date	Person	Action	Amount	type
2023-11-17	Aselage Steve	Sell	483 741	Common Stock, $0.0001 par value per share
2023-11-17	Dunn John Michael	Sell	27 380	Common Stock, $0.0001 par value per share
2023-11-17	Joseph Donald	Sell	14 285	Common Stock, $0.0001 par value per share
2023-11-17	Schelling Chris	Sell	2 712 529	Common Stock, $0.0001 par value per share
2023-11-17	Palmin Harry S	Sell	125 000	Common Stock, $0.0001 par value per share

INSIDER POWER
-67.24
Last 96 transactions
Buy: 5 870 002 \| Sell: 3 622 222

Volume Correlation

Long: 0.50 (weak)

Short: -0.98 (very strong negative)

Signal:(30.163) Neutral

Acer Therapeutics Inc Correlation

10 Most Positive Correlations
BIRD	0.965
CNTY	0.965
COLB	0.964
FTXO	0.963
KBWB	0.962
AIRG	0.961
FITB	0.961
CPTN	0.96
PRCH	0.958
EVLO	0.957

10 Most Negative Correlations
OPNT	-0.949
DVCR	-0.944
DSEY	-0.941
AMYT	-0.935
CCRC	-0.933
SUMO	-0.93
DAKT	-0.919
SGEN	-0.918
BTBD	-0.917
PPYAU	-0.913

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Acer Therapeutics Inc Correlation - Currency/Commodity

-0.15
( neutral )

-0.28
( neutral )

0.00
( neutral )

-0.18
( neutral )

-0.49
( neutral )

0.27
( neutral )

Acer Therapeutics Inc Financials

Annual	2022
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$-1.770

Q3	2023
Revenue:	$371 790
Gross Profit:	$287 985 (77.46 %)
EPS:	$-0.600

Q2	2023
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$-0.330

Q1	2023
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$-1.270

Financial Reports:

No articles found.

Acer Therapeutics Inc

Acer Therapeutics Inc., a pharmaceutical company, focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. Its pipeline includes four clinical-stage candidates comprising EDSIVO for the treatment of vascular Ehlers-Danlos Syndrome in patients with a confirmed type III collagen mutation; ACER-001, a formulation of sodium phenylbutyrate for the treatment of various inborn errors of metabolism, including urea cycle disorders and maple syrup urine disease; ACER-801 (osanetant) for the treatment of induced Vasomotor Symptoms; and ACER-2820 (emetine), a host-directed therapy against a variety of infectious diseases, including COVID-19. The company has a research collaboration agreement with the National Center for Advancing Translational Sciences (NCATS) to develop emetine hydrochloride as a potential treatment for patients with COVID-19; and a license agreement with Sanofi to acquire worldwide rights to osanetant, a clinical-stage, selective, and non-peptide tachykinin NK3 receptor antagonist. Acer Therapeutics Inc. was incorporated in 1991 and is headquartered in Newton, Massachusetts.